Drugmakers eye a new threat to sales but say it hasn’t affected them — yet By: MarketWatch May 01, 2018 at 12:18 PM EDT The issue is being watched closely by the industry and many Wall Street analysts and could manifest as soon as the next quarter. Read More >> Related Stocks: AbbVie Amgen Biogen Idec Eli Lilly HEALTHCARE Novartis Ag ADR Pfizer S&P Pharmaceuticals SPDR Sanofi-Aventis S.A. ADR